Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III EXPLORER-HCM trial has demonstrated that the novel cardiac myosin inhibitor ...
Health systems across Canada need to implement more non-pharmacological programs to provide comprehensive dementia care in an ...
The FDA granted accelerated approval to talquetamab on August 9, 2023, as a treatment option for adult patients with relapsed/refractory multiple myeloma (RRMM) who have failed at least 4 prior lines ...
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial We derived disease progression and therapy ...
Please provide your email address to receive an email when new articles are posted on . For patients with obesity, bariatric surgery was more cost-effective than GLP-1 receptor agonists. The biggest ...
Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening. Objectives: ...
Forbes contributors publish independent expert analyses and insights. A study just published in JAMA could unveil a new direction in the landscape of weight loss interventions. Endoscopic sleeve ...
Please provide your email address to receive an email when new articles are posted on . Ensifentrine plus maintenance therapy yielded multiple benefits in patients with moderate to severe COPD. If ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results